Who owns Boston Scientific (BSX)? Superinvestor holders
13 superinvestors of the 157 tracked here hold Boston Scientific (BSX) in their latest 13F filing, with $6.5B between them. Andrew Spokes gives it the most weight: 2.57% of the reported portfolio. In their latest reported quarter, Steven Romick and Larry Robbins opened a position; Andrew Spokes, Lee Ainslie, Primecap team and Louis Bacon and 6 more added.
Eric Bannasch, Doug Silverman, Stephen Mandel and Polen Capital team sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 13 of 157
- Biggest holder
- Primecap team, $2.6B
- Largest weight
- Andrew Spokes, 2.57%of their portfolio
- Combined value
- $6.5B
- Bought last quarter
- 12
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Andrew SpokesFarallon Capital Management | 2.57% | $492.7M | 11.29M | ▲ Added 7.3% | +765.95K | Q3 2026 |
| 2 | Lee AinslieMaverick Capital | 2.29% | $253.4M | 5.94M | ▲ Added 42% | +1.74M | Q2 2026 |
| 3 | Primecap teamPrimecap Management | 1.59% | $2.6B | 58.62M | ▲ Added 16% | +8.1M | Q3 2026 |
| 4 | Steven RomickFirst Pacific Advisors (FPA) | 1.22% | $102.3M | 2.34M | New | +2.34M | Q3 2026 |
| 5 | Louis BaconMoore Capital Management | 0.84% | $29.8M | 681.86K | ▲ Added 260% | +492.61K | Q3 2026 |
| 6 | David Shaw (founder)D. E. Shaw & Co. | 0.67% | $1.1B | 25.46M | ▲ Added 4.7% | +1.15M | Q2 2026 |
| 7 | John Overdeck and David Siegel (founders)Two Sigma Investments | 0.63% | $873.3M | 20.01M | ▲ Added 3.4% | +648.5K | Q3 2026 |
| 8 | Sarah KettererCauseway Capital Management | 0.44% | $39.1M | 895.32K | ▲ Added 24% | +174.97K | Q3 2026 |
| 9 | Dodge & Cox teamDodge & Cox | 0.35% | $653.1M | 14.96M | ▲ Added more than 10× | +14.87M | Q3 2026 |
| 10 | TemasekTemasek Holdings | 0.29% | $104.7M | 2.4M | No change | 0 | Q3 2026 |
| 11 | Paul Tudor JonesTudor Investment Corp | 0.26% | $63.1M | 1.48M | ▲ Added 134% | +845.09K | Q2 2026 |
| 12 | Israel EnglanderMillennium Management | 0.14% | $210.7M | 5.44M | ▲ Added 25% | +1.1M | Q2 2026 |
| 13 | Larry RobbinsGlenview Capital Management | 0.10% | $4.8M | 113.1K | New | +113.1K | Q2 2026 |
Sold out last quarter
- Eric Bannaschwas $47.2M · Q3 2026
- Doug Silvermanwas $12.8M · Q3 2026
- Stephen Mandelwas $6.6M · Q2 2026
- Polen Capital teamwas $202.7K · Q3 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 8 | 111.2M | $4.9B | 7 | 3 |
| Q2 2026 | 157 | 15 | 123.78M | $5.3B | 13 | 3 |
| Q1 2026 | 157 | 18 | 101.6M | $6.3B | 9 | 11 |
| Q4 2025 | 157 | 20 | 105.74M | $10B | 13 | 6 |
| Q3 2025 | 157 | 17 | 96.03M | $9.3B | 10 | 9 |
| Q2 2025 | 157 | 18 | 81.7M | $8.7B | 11 | 7 |
| Q1 2025 | 156 | 17 | 76.72M | $7.7B | 7 | 9 |
| Q4 2024 | 156 | 15 | 73.2M | $6.5B | 4 | 11 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Primecap team | 58.62M | 50.52M | 32.53M | 31.1M | 33.1M | 34.66M | 36.5M | 36.93M |
| John Overdeck and David Siegel (founders) | 20.01M | 19.36M | 9.41M | 2.47M | 2.53M | 2.47M | 2.44M | — |
| Dodge & Cox team | 14.96M | 87.49K | 88.89K | 88.89K | 88.89K | 90.39K | 91.7K | 94.8K |
| Andrew Spokes | 11.29M | 10.52M | 7.47M | 7.44M | 4.75M | 3.98M | 3.76M | 5.02M |
| Temasek | 2.4M | 2.4M | 2.4M | 2.08M | 1.68M | 1.09M | 1.09M | 406.49K |
| Steven Romick | 2.34M | — | — | — | — | — | — | — |
| Sarah Ketterer | 895.32K | 720.34K | — | — | — | — | — | — |
| Louis Bacon | 681.86K | 189.26K | — | — | — | — | — | — |
| David Shaw (founder) | · | 25.46M | 24.31M | 11.25M | 8.91M | 6.76M | 3.84M | — |
| Lee Ainslie | · | 5.94M | 4.2M | 2.94M | — | — | — | — |
| Israel Englander | · | 5.44M | 4.34M | 11.26M | 8.52M | 4.64M | 8.34M | 9.13M |
| Paul Tudor Jones | · | 1.48M | 632.55K | 732.84K | 660.19K | 650.62K | 256.13K | — |
| Eric Bannasch | — | 1.11M | 170K | — | — | — | — | — |
| Doug Silverman | — | 300K | — | — | — | — | — | 450K |
| Diamond Hill team | — | 157.83K | 150.11K | 250.21K | 278.07K | 331.27K | 392.38K | 473.7K |
| Larry Robbins | · | 113.1K | — | — | — | — | — | — |
| Ken Griffin | · | — | 4.22M | 4.78M | 8.91M | 5.4M | 5.43M | 4.93M |
| Steve Cohen | · | — | 3.69M | 2.43M | 1.63M | 2.46M | 1.88M | 2.25M |
| Brandon Haley | · | — | 3.43M | 4.47M | 2.95M | 4.18M | 1.89M | 3.06M |
| Jim Simons (1938–2024) | — | — | 3.15M | 2.38M | — | 1.5M | — | — |
| Frank Sands | — | — | 736.11K | 805.16K | — | — | — | — |
| Polen Capital team | — | — | 579.74K | 4.02M | 5.6M | — | — | — |
| Stephen Mandel | · | — | 104.66K | 201.7K | — | — | — | — |
| Ken Fisher | — | — | — | 9.14M | 8.46M | 7.71M | 6.77M | 5.8M |
| John Armitage | — | — | — | 5.39M | 5.31M | 1.64M | — | — |
| Andreas Halvorsen | · | — | — | 2.51M | 2.64M | 3.05M | 2.38M | 2.17M |
| Mairs & Power team | — | — | — | — | 10.31K | 10.41K | 10.31K | 10.31K |
| Robert Pitts | · | — | — | — | — | 1.1M | 1.56M | 2.38M |
| George Soros | — | — | — | — | — | — | 100K | 100K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own BSX?
In their latest 13F filings: Andrew Spokes (2.57% of the portfolio, $492.7M), Lee Ainslie (2.29% of the portfolio, $253.4M), Primecap team (1.59% of the portfolio, $2.6B), Steven Romick (1.22% of the portfolio, $102.3M), Louis Bacon (0.84% of the portfolio, $29.8M), David Shaw (founder) (0.67% of the portfolio, $1.1B), John Overdeck and David Siegel (founders) (0.63% of the portfolio, $873.3M), Sarah Ketterer (0.44% of the portfolio, $39.1M), and 5 more.
Who bought BSX last quarter?
Andrew Spokes (added 7.3%), Lee Ainslie (added 42%), Primecap team (added 16%), Steven Romick (new position), Louis Bacon (added 260%), David Shaw (founder) (added 4.7%), John Overdeck and David Siegel (founders) (added 3.4%), Sarah Ketterer (added 24%). “Last quarter” is each investor's latest reported quarter.
Who sold BSX last quarter?
Sold out entirely: Eric Bannasch (was $47.2M), Doug Silverman (was $12.8M), Stephen Mandel (was $6.6M), Polen Capital team (was $202.7K).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Boston Scientific (BSX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/BSX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to BSX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.